CVS takes on Mylan's EpiPen with much cheaper version of an alternative – MarketWatch
MarketWatch |
CVS takes on Mylan’s EpiPen with much cheaper version of an alternative
MarketWatch “As a health care company focused on helping people on their path to better health, we recognized that there was an urgent need in the marketplace for a less expensive epinephrine auto-injector for patients with life-threatening allergies,” CVS … CVS just announced a super cheap generic alternative to EpiPen |
Powered by WPeMatico
